drugset / Trial / NCT00553657

The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder

NCT00553657

Phase 1 Completed 55 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to determine if standardizing fluid intake in a clinic setting will reduce variability of individual voiding parameters and potentially serve as a way to limit patient exposure in the initial assessment of efficacy of compounds being developed for Overactive Bladder.

Timeline

Start
2007-08
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Background Tolterodine Small molecule

Indications